IDEXX Laboratories, Inc. (IDXX) Net Profit Margin: 24.62%
Is IDEXX Laboratories, Inc.’s net profit margin high or low?
IDEXX Laboratories, Inc.'s net profit margin of 24.62% is in line with its 5-year average of 22.55%, near the high end of its 5-year range (20.17%–24.62%).
The net profit margin for IDEXX Laboratories, Inc. (IDXX) is 24.62% as of Tuesday, June 9, 2026. It is above its 12-month average by 3.88% (23.70%).
IDXX Net Profit Margin Chart
IDXX Average Net Profit Margin Chart
IDXX Current vs Average Net Profit Margin Chart
IDXX Net Profit Margin Metrics
NET PROFIT MARGIN
24.62%
NET PROFIT MARGIN AVG TTM
23.70%
NET PROFIT MARGIN AVG 3Y
22.66%
NET PROFIT MARGIN AVG 5Y
22.55%
NET PROFIT MARGIN AVG 10Y
18.91%
NET PROFIT MARGIN AVG 15Y
17.11%
NET PROFIT MARGIN AVG 20Y
15.81%
CURRENT VS TTM AVG
+3.88%
CURRENT VS 3Y AVG
+8.64%
CURRENT VS 5Y AVG
+9.17%
CURRENT VS 10Y AVG
+30.21%
CURRENT VS 15Y AVG
+43.91%
CURRENT VS 20Y AVG
+55.71%
IDXX Competitors' Net Profit Margin
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IDEXX Laboratories, Inc. (IDXX) | — | 24.62% | 23.70% | 22.66% | 22.55% |
| Humana Inc. (HUM) | $43.60B | 0.92% | 0.97% | 1.82% | 2.53% |
| Agilent Technologies, Inc. (A) | $38.26B | 18.75% | 19.27% | 18.75% | 17.94% |
| Zoetis Inc. (ZTS) | $34.46B | 28.23% | 27.55% | 27.17% | 26.57% |
| Centene Corporation (CNC) | $32.69B | -3.43% | -0.70% | 0.29% | 0.65% |
| IQVIA Holdings Inc. (IQV) | $31.09B | 8.34% | 8.63% | 8.47% | 7.22% |
| DexCom, Inc. (DXCM) | $30.17B | 17.94% | 16.12% | 14.73% | 15.57% |
| Biogen Inc. (BIIB) | $29.39B | 13.18% | 15.03% | 17.95% | 19.29% |
| Regeneron Pharmaceuticals, Inc. (REGN) | $63.48B | 31.41% | 31.24% | 32.06% | 36.64% |
| Veeva Systems Inc. (VEEV) | $27.37B | 28.44% | 27.22% | 24.83% | 24.72% |
Margin Comparison
Operating Margin
31.6%
Net Profit Margin
24.6%
IDEXX Laboratories, Inc. Net Profit Margin Formula & Definition
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
IDEXX Laboratories, Inc. Net Profit Margin FAQ
- What is the net profit margin for IDEXX Laboratories, Inc. (IDXX)?
- The net profit margin for IDXX stock is 24.62%.
- Is IDEXX Laboratories, Inc.'s net profit margin high or low?
- IDEXX Laboratories, Inc.'s net profit margin of 24.62% is in line with its 5-year average of 22.55%, near the high end of its 5-year range (20.17%–24.62%).
- What is the TTM average net profit margin for IDEXX Laboratories, Inc. (IDXX)?
- The TTM average net profit margin for IDXX stock is 23.70%.
- What is the 3Y average net profit margin for IDEXX Laboratories, Inc. (IDXX)?
- The 3Y average net profit margin for IDXX stock is 22.66%.
- What is the 5Y average net profit margin for IDEXX Laboratories, Inc. (IDXX)?
- The 5Y average net profit margin for IDXX stock is 22.55%.
- What is the 10Y average net profit margin for IDEXX Laboratories, Inc. (IDXX)?
- The 10Y average net profit margin for IDXX stock is 18.91%.
- What is the 15Y average net profit margin for IDEXX Laboratories, Inc. (IDXX)?
- The 15Y average net profit margin for IDXX stock is 17.11%.
- What is the 20Y average net profit margin for IDEXX Laboratories, Inc. (IDXX)?
- The 20Y average net profit margin for IDXX stock is 15.81%.
IDEXX Laboratories, Inc. Net Profit Margin History
| DATE | NET PROFIT MARGIN |
|---|---|
| 2025-12-31 | 24.62% |
| 2024-12-31 | 22.78% |
| 2023-12-31 | 23.08% |
| 2022-12-31 | 20.17% |
| 2021-12-31 | 23.17% |
| 2020-12-31 | 21.49% |
| 2019-12-31 | 17.77% |
| 2018-12-31 | 17.04% |
| 2017-12-31 | 13.36% |
| 2016-12-31 | 12.51% |
| 2015-12-31 | 11.99% |
| 2014-12-31 | 12.24% |
| 2013-12-31 | 13.64% |
| 2012-12-31 | 13.78% |
| 2011-12-31 | 13.28% |
| 2010-12-31 | 12.80% |
| 2009-12-31 | 11.85% |
| 2008-12-31 | 11.34% |
| 2007-12-31 | 10.19% |
| 2006-12-31 | 12.67% |
| 2005-12-31 | 12.26% |
| 2004-12-31 | 14.26% |
| 2003-12-31 | 11.99% |
| 2002-12-31 | 11.00% |
| 2001-12-31 | 9.74% |
| 2000-12-31 | 9.97% |
| 1999-12-31 | 9.15% |
| 1998-12-31 | -4.75% |
| 1997-12-31 | -8.02% |
| 1996-12-31 | 12.18% |
Related Metrics
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Jonathan J. Mazelsky